Sulphacetamide SodiumThird Party Manufacturing in India

Sulphacetamide Sodium is a sulfonamide antibiotic that works by inhibiting bacterial folic acid synthesis. It acts as a competitive antagonist of para-aminobenzoic acid (PABA), an essential substrate required by bacteria for synthesizing dihydrofolic acid. By blocking the enzyme dihydropteroate synthase, sulphacetamide prevents the conversion of PABA into folic acid, which is necessary for bacterial nucleic acid synthesis and cell growth.

This mechanism makes sulphacetamide a bacteriostatic agent — it stops bacteria from multiplying rather than killing them directly, allowing the immune system to clear the infection. It is active against a broad range of Gram-positive and Gram-negative bacteria, including Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, and Chlamydia trachomatis. Its high solubility at physiological pH makes it particularly well-suited for ophthalmic and topical applications where good tissue penetration is essential.

Therapeutic Uses

Sulphacetamide Sodium is indicated for the treatment of:

• Ophthalmic Infections: Effective against conjunctivitis, blepharitis, keratitis, and corneal ulcers caused by susceptible bacteria
• Seborrheic Dermatitis: Used in topical formulations to manage dandruff and scalp inflammation
• Acne Vulgaris: Combined with sulfur in topical preparations for acne treatment
• Urinary Tract Infections: Oral administration for uncomplicated UTIs caused by susceptible organisms
• Skin Infections: Topical treatment of bacterial skin infections and pyoderma

Why Manufacturers Choose Sulphacetamide Sodium

Sulphacetamide is one of the most cost-effective sulfonamide antibiotics and enjoys steady demand in both human and veterinary medicine. Its high aqueous solubility makes it versatile for multiple dosage forms — eye drops, topical lotions, creams, and injectable solutions. Indian manufacturers with WHO-GMP certified facilities are major suppliers of sulphacetamide formulations to South Asia, the Middle East, Africa, and Latin America, where affordability and proven efficacy drive procurement decisions.

This makes Sulphacetamide Sodium a reliable molecule for third party manufacturing in India, with consistent demand from PCD franchise networks and institutional buyers across developing healthcare markets.